Vaporizing Cannabis: Possible Treatment For Neuropathic Pain Symptoms

A recent study performed in California found Cannabis to be successful in reducing neuropathic pain intensity. Researchers at the University of California, Davis recently completed a study on the effects of vaporized cannabis on neuropathic pain. The study was sponsored by the Center for Medicinal Cannabis Research and the VA Northern California Health Care System.

Neuropathic pain is an result of nerve damage. It causes sensations like: pins & needles, itching, wetness, and burning.

Neuropathic pain refers to the perception of pain when there is no reason, biologically. It is the result of damage or disease to thesomatosensory system, which controls the sensations associated with touch. The somatosensory system covers the skin, bones, joints, skeletal muscles, and internal organs; it is responsible for the perception of pain, temperature, and tactile touch.

Continue Reading


Most people have heard of a chemical called THC, which is the ingredient in marijuana that gets users high. But recently, attention has shifted to another compound in marijuana called CBD — and for good reason.

Because while doctors can’t seem to look past certain side effects of THC, CBD doesn’t seem to present that problem. On the other hand, evidence of CBD’s medical benefits continues to grow.

Here are five facts that you should know about this unique compound:


CBD is one of over 60 compounds found in cannabis that belong to a class of molecules called cannabinoids. Of these compounds, CBD and THC are usually present in the highest concentrations, and are therefore the most recognized and studied.

CBD and THC levels tend to vary among different plants. Marijuana grown for recreational purposes often contains more THC than CBD.

However, by using selective breeding techniques, cannabis breeders have managed to create varieties with high levels of CBD and next to zero levels of THC. These strains are rare but have become more popular in recent years.

Continue Reading

A Brief Overview Of Cannabinoid-Based Medicines As Potential Treatments For Brain Injuries

In a recent study titled “Effect of Marijuana Use on Outcomes in Traumatic Brain Injury” and published in The American Surgeon, researchers
found that patients who had detectable levels of THC in their bodies were less likely than those who did not to die as a result of traumatic brain injury (TBI). The retrospective study examined the data of 446 cases of TBI over a three year period, involving patients who had been treated at Harbor-UCLA Medical Center in Torrance, CA.

THC Helps Prevent Death Resulting From Traumatic Brain Injury

Overall, 18.4% of TBI patients in the sample had toxicology reports positive for the presence of THC, and the death rate for all cases examined was 9.9%. After adjusting for differences that may confound results (such as age, gender, and classification of injury), the death rate for TBI patients with THC-negative toxicology reports (i.e. without detectable levels of THC in their body) was 11.5%, but for TBI patients with THC-positive reports was only 2.4%. Therefore, the survival of THC-positive TBI patients was approximately 80 times more than the survival of THC-negative TBI patients.

Continue Reading

Ultra-Low Doses Of THC May Help Protect Against Neurodegenerative Diseases

There is a great deal of evidence suggesting that cannabis could be beneficial for the prevention and treatment of neurodegenerative diseases like Alzheimer’s disease and Parkinson’s. In fact, a Brazilian study published last year suggests that cannabidiol (CBD) could help ward off neuronal cell death in the face of neurodegradation.

In order to provide more insight on the topic of medical marijuana and neurodegenerative disease, a team of researchers from Tel-Aviv University in Israel published a study in the Journal of Neuroscience Research last month. Their results suggest that ultra-low doses of cannabinoids, andtetrahydrocannabinol (THC) in particular, can help protect against cognitive deficits that arise as a result of inflammation in the brain.

Continue Reading

Report to the Legislature and Governor of the State of California

In 1999, the California legislature passed and Governor Gray Davis signed SB847, which commissioned the University of California to establish a scientific research program to expand the public scientific knowledge on purported therapeutic usages of marijuana.

Read the Report HERE.

MMJ Edibles Delivered to You